CHAMPIONX CORP (CHX) Fundamental Analysis & Valuation

NASDAQ:CHXUS15872M1045

Current stock price

25.81 USD
-0.79 (-2.97%)
At close:
25.83 USD
+0.02 (+0.08%)
After Hours:

This CHX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. CHX Profitability Analysis

1.1 Basic Checks

  • In the past year CHX was profitable.
  • CHX had a positive operating cash flow in the past year.
  • CHX had positive earnings in 4 of the past 5 years.
  • In the past 5 years CHX always reported a positive cash flow from operatings.
CHX Yearly Net Income VS EBIT VS OCF VS FCFCHX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 8.37%, CHX is in the better half of the industry, outperforming 79.03% of the companies in the same industry.
  • CHX has a Return On Equity of 15.29%. This is in the better half of the industry: CHX outperforms 77.42% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 14.15%, CHX belongs to the top of the industry, outperforming 88.71% of the companies in the same industry.
  • CHX had an Average Return On Invested Capital over the past 3 years of 13.65%. This is in line with the industry average of 13.38%.
  • The 3 year average ROIC (13.65%) for CHX is below the current ROIC(14.15%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.37%
ROE 15.29%
ROIC 14.15%
ROA(3y)7.83%
ROA(5y)1.06%
ROE(3y)15.08%
ROE(5y)1.18%
ROIC(3y)13.65%
ROIC(5y)9.48%
CHX Yearly ROA, ROE, ROICCHX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

  • CHX's Profit Margin of 8.20% is fine compared to the rest of the industry. CHX outperforms 66.13% of its industry peers.
  • CHX's Profit Margin has improved in the last couple of years.
  • CHX has a Operating Margin of 14.41%. This is in the better half of the industry: CHX outperforms 72.58% of its industry peers.
  • In the last couple of years the Operating Margin of CHX has grown nicely.
  • Looking at the Gross Margin, with a value of 33.16%, CHX is in the better half of the industry, outperforming 62.90% of the companies in the same industry.
  • In the last couple of years the Gross Margin of CHX has remained more or less at the same level.
Industry RankSector Rank
OM 14.41%
PM (TTM) 8.2%
GM 33.16%
OM growth 3Y32.96%
OM growth 5Y8.66%
PM growth 3Y33.74%
PM growth 5Y13.82%
GM growth 3Y10.44%
GM growth 5Y-0.48%
CHX Yearly Profit, Operating, Gross MarginsCHX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

8

2. CHX Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CHX is creating some value.
  • The number of shares outstanding for CHX has been reduced compared to 1 year ago.
  • The number of shares outstanding for CHX has been increased compared to 5 years ago.
  • CHX has a better debt/assets ratio than last year.
CHX Yearly Shares OutstandingCHX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CHX Yearly Total Debt VS Total AssetsCHX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

  • CHX has an Altman-Z score of 3.65. This indicates that CHX is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of CHX (3.65) is better than 85.48% of its industry peers.
  • CHX has a debt to FCF ratio of 1.74. This is a very positive value and a sign of high solvency as it would only need 1.74 years to pay back of all of its debts.
  • CHX has a better Debt to FCF ratio (1.74) than 80.65% of its industry peers.
  • A Debt/Equity ratio of 0.31 indicates that CHX is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.31, CHX is in the better half of the industry, outperforming 61.29% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 1.74
Altman-Z 3.65
ROIC/WACC1.51
WACC9.37%
CHX Yearly LT Debt VS Equity VS FCFCHX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

  • CHX has a Current Ratio of 2.25. This indicates that CHX is financially healthy and has no problem in meeting its short term obligations.
  • CHX's Current ratio of 2.25 is fine compared to the rest of the industry. CHX outperforms 67.74% of its industry peers.
  • CHX has a Quick Ratio of 1.62. This is a normal value and indicates that CHX is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of CHX (1.62) is better than 61.29% of its industry peers.
Industry RankSector Rank
Current Ratio 2.25
Quick Ratio 1.62
CHX Yearly Current Assets VS Current LiabilitesCHX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. CHX Growth Analysis

3.1 Past

  • The earnings per share for CHX have decreased by -1.63% in the last year.
  • Measured over the past years, CHX shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.09% on average per year.
  • CHX shows a decrease in Revenue. In the last year, the revenue decreased by -4.17%.
  • Measured over the past years, CHX shows a very strong growth in Revenue. The Revenue has been growing by 26.29% on average per year.
EPS 1Y (TTM)-1.63%
EPS 3Y44.49%
EPS 5Y11.09%
EPS Q2Q%0%
Revenue 1Y (TTM)-4.17%
Revenue growth 3Y5.73%
Revenue growth 5Y26.29%
Sales Q2Q%-6.25%

3.2 Future

  • The Earnings Per Share is expected to grow by 6.80% on average over the next years.
  • Based on estimates for the next years, CHX will show a small growth in Revenue. The Revenue will grow by 2.82% on average per year.
EPS Next Y6.36%
EPS Next 2Y3.8%
EPS Next 3Y5.08%
EPS Next 5Y6.8%
Revenue Next Year-5.3%
Revenue Next 2Y-2.49%
Revenue Next 3Y-1.12%
Revenue Next 5Y2.82%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CHX Yearly Revenue VS EstimatesCHX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B 5B
CHX Yearly EPS VS EstimatesCHX Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3

4

4. CHX Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 14.26, which indicates a correct valuation of CHX.
  • 64.52% of the companies in the same industry are more expensive than CHX, based on the Price/Earnings ratio.
  • CHX's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.60.
  • Based on the Price/Forward Earnings ratio of 13.24, the valuation of CHX can be described as correct.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CHX is on the same level as its industry peers.
  • CHX's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.84.
Industry RankSector Rank
PE 14.26
Fwd PE 13.24
CHX Price Earnings VS Forward Price EarningsCHX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • CHX's Enterprise Value to EBITDA is on the same level as the industry average.
  • CHX's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 14.43
EV/EBITDA 6.58
CHX Per share dataCHX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CHX does not grow enough to justify the current Price/Earnings ratio.
  • CHX has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.24
PEG (5Y)1.29
EPS Next 2Y3.8%
EPS Next 3Y5.08%

3

5. CHX Dividend Analysis

5.1 Amount

  • CHX has a Yearly Dividend Yield of 1.47%.
  • Compared to an average industry Dividend Yield of 0.96, CHX pays a bit more dividend than its industry peers.
  • CHX's Dividend Yield is slightly below the S&P500 average, which is at 1.88.
Industry RankSector Rank
Dividend Yield 1.47%

5.2 History

  • The dividend of CHX decreases each year by -47.78%.
  • CHX has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)-47.78%
Div Incr Years2
Div Non Decr Years2
CHX Yearly Dividends per shareCHX Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.1 0.2 0.3

5.3 Sustainability

  • CHX pays out 24.70% of its income as dividend. This is a sustainable payout ratio.
DP24.7%
EPS Next 2Y3.8%
EPS Next 3Y5.08%
CHX Yearly Income VS Free CF VS DividendCHX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M
CHX Dividend Payout.CHX Dividend Payout, showing the Payout Ratio.CHX Dividend Payout.PayoutRetained Earnings

CHX Fundamentals: All Metrics, Ratios and Statistics

CHAMPIONX CORP

NASDAQ:CHX (7/15/2025, 8:00:00 PM)

After market: 25.83 +0.02 (+0.08%)

25.81

-0.79 (-2.97%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)07-18
Earnings (Next)10-21
Inst Owners95.44%
Inst Owner Change-98.35%
Ins Owners0.99%
Ins Owner Change0%
Market Cap4.94B
Revenue(TTM)3.58B
Net Income(TTM)293.14M
Analysts86.67
Price Target42.23 (63.62%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.47%
Yearly Dividend0.37
Dividend Growth(5Y)-47.78%
DP24.7%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.44%
Min EPS beat(2)0.36%
Max EPS beat(2)14.53%
EPS beat(4)2
Avg EPS beat(4)-2.36%
Min EPS beat(4)-19.69%
Max EPS beat(4)14.53%
EPS beat(8)4
Avg EPS beat(8)0.56%
EPS beat(12)8
Avg EPS beat(12)1.75%
EPS beat(16)11
Avg EPS beat(16)1.71%
Revenue beat(2)0
Avg Revenue beat(2)-2.81%
Min Revenue beat(2)-4.47%
Max Revenue beat(2)-1.16%
Revenue beat(4)0
Avg Revenue beat(4)-4.29%
Min Revenue beat(4)-7.8%
Max Revenue beat(4)-1.16%
Revenue beat(8)0
Avg Revenue beat(8)-3.77%
Revenue beat(12)2
Avg Revenue beat(12)-2.06%
Revenue beat(16)5
Avg Revenue beat(16)-1.12%
PT rev (1m)0%
PT rev (3m)-1.9%
EPS NQ rev (1m)-2.98%
EPS NQ rev (3m)-4.17%
EPS NY rev (1m)-6.47%
EPS NY rev (3m)-10.47%
Revenue NQ rev (1m)-1.62%
Revenue NQ rev (3m)-4.6%
Revenue NY rev (1m)-2.24%
Revenue NY rev (3m)-7.4%
Valuation
Industry RankSector Rank
PE 14.26
Fwd PE 13.24
P/S 1.38
P/FCF 14.43
P/OCF 10.23
P/B 2.58
P/tB 4.71
EV/EBITDA 6.58
EPS(TTM)1.81
EY7.01%
EPS(NY)1.95
Fwd EY7.56%
FCF(TTM)1.79
FCFY6.93%
OCF(TTM)2.52
OCFY9.77%
SpS18.68
BVpS10.01
TBVpS5.48
PEG (NY)2.24
PEG (5Y)1.29
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 8.37%
ROE 15.29%
ROCE 18.98%
ROIC 14.15%
ROICexc 17.55%
ROICexgc 29.07%
OM 14.41%
PM (TTM) 8.2%
GM 33.16%
FCFM 9.57%
ROA(3y)7.83%
ROA(5y)1.06%
ROE(3y)15.08%
ROE(5y)1.18%
ROIC(3y)13.65%
ROIC(5y)9.48%
ROICexc(3y)15.86%
ROICexc(5y)10.93%
ROICexgc(3y)28.04%
ROICexgc(5y)19.36%
ROCE(3y)18.31%
ROCE(5y)12.72%
ROICexgc growth 3Y47.18%
ROICexgc growth 5Y16.9%
ROICexc growth 3Y46.83%
ROICexc growth 5Y30.42%
OM growth 3Y32.96%
OM growth 5Y8.66%
PM growth 3Y33.74%
PM growth 5Y13.82%
GM growth 3Y10.44%
GM growth 5Y-0.48%
F-Score6
Asset Turnover1.02
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 1.74
Debt/EBITDA 0.78
Cap/Depr 57.1%
Cap/Sales 3.93%
Interest Coverage 250
Cash Conversion 63.4%
Profit Quality 116.78%
Current Ratio 2.25
Quick Ratio 1.62
Altman-Z 3.65
F-Score6
WACC9.37%
ROIC/WACC1.51
Cap/Depr(3y)53.43%
Cap/Depr(5y)43.4%
Cap/Sales(3y)3.46%
Cap/Sales(5y)3.1%
Profit Quality(3y)155.68%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.63%
EPS 3Y44.49%
EPS 5Y11.09%
EPS Q2Q%0%
EPS Next Y6.36%
EPS Next 2Y3.8%
EPS Next 3Y5.08%
EPS Next 5Y6.8%
Revenue 1Y (TTM)-4.17%
Revenue growth 3Y5.73%
Revenue growth 5Y26.29%
Sales Q2Q%-6.25%
Revenue Next Year-5.3%
Revenue Next 2Y-2.49%
Revenue Next 3Y-1.12%
Revenue Next 5Y2.82%
EBIT growth 1Y0.17%
EBIT growth 3Y40.57%
EBIT growth 5Y37.22%
EBIT Next Year52.58%
EBIT Next 3Y14.47%
EBIT Next 5Y9.48%
FCF growth 1Y-23.96%
FCF growth 3Y22.54%
FCF growth 5Y31.03%
OCF growth 1Y-12.01%
OCF growth 3Y21.57%
OCF growth 5Y30.48%

CHAMPIONX CORP / CHX Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CHAMPIONX CORP (CHX) stock?

ChartMill assigns a fundamental rating of 6 / 10 to CHX.


Can you provide the valuation status for CHAMPIONX CORP?

ChartMill assigns a valuation rating of 4 / 10 to CHAMPIONX CORP (CHX). This can be considered as Fairly Valued.


How profitable is CHAMPIONX CORP (CHX) stock?

CHAMPIONX CORP (CHX) has a profitability rating of 8 / 10.


What is the valuation of CHAMPIONX CORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for CHAMPIONX CORP (CHX) is 14.26 and the Price/Book (PB) ratio is 2.58.


Can you provide the financial health for CHX stock?

The financial health rating of CHAMPIONX CORP (CHX) is 8 / 10.